Education
About Us
Working with TipRanks
Follow Us
Alison Hannah Insider Profile
4 Followers
Alison Hannah, Director at NeoGenomics, holds 118.77K shares in NeoGenomics (Ticker: NEO), holds 81.25K shares in Rigel (Ticker: RIGL), holds 31.90K shares in CytomX Therapeutics (Ticker: CTMX).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+14.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alison Hannah holds in companies
Most Profitable Insider Trade
The most profitable trade made by Alison Hannah
Alison Hannah's Trading History
NeoGenomics
Aug 13, 2024
Director
Uninformative Buy
187.61K
$1.20M
CytomX Therapeutics
Jul 21, 2022
CMO
Uninformative Buy
―
$21.18K
Rigel
May 29, 2024
Director
Uninformative Buy
―
$1.67M
List of latest transactions for each holding click on a transaction to see Alison Hannah's performance on stock
You May Also Like
Alison Hannah insider profile FAQ
What is the percentage of profitable transactions made by Alison Hannah?
The percentage of profitable transactions made by Alison Hannah is 67%.
What is the average return per transaction made by Alison Hannah?
The average return per transaction made by Alison Hannah is 14.70%.
What stocks does Alison Hannah hold?
Alison Hannah holds: NEO, CTMX, RIGL stocks.
What was Alison Hannah’s latest transaction?
Alison Hannah latest transaction was an Uninformative Buy of $187.61K.
What was Alison Hannah's most profitable transaction?
Alison Hannah’s most profitable transaction was an Informative Buy of NEO stock on July 31, 2017. The return on the trade was 48.10%.
What is Alison Hannah's role in NeoGenomics?
Alison Hannah's role in NeoGenomics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.